Feb. 10 at 2:00 PM
$SANA Sana Biotechnology (SANA) closed the last trading session at
$5, gaining 10.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of
$8.71 indicates a 74.2% upside potential.
The average comprises seven short-term price targets ranging from a low of
$6.00 to a high of
$12.00, with a standard deviation of
$2.43. While the lowest estimate indicates an increase of 20% from the current price level, the most optimistic estimate points to a 140% upside
